Abstract
The effect of exogenous leukotriene B4 (LTB4) on opsonized zymosan-stimulated human neutrophil formation of 5-lipoxygenase products and arachidonic acid release was directly assessed using reverse-phase HPLC/tandem mass spectrometric methods for quantitation. Stable isotopically labeled LTB4, [1,2-13C2]LTB4, caused a dose-dependent inhibition of LTB4 production in isolated human neutrophils with significant inhibition (60 ± 7% of control levels) when 0.12 nM [13C2]LTB4 was present. Production of 5-hydroxy-6,8,11,14-eicosatetraenoic acid and release of free arachidonic acid were also dose-dependently inhibited by exogenous LTB4. Metabolites of LTB4, 20-hydroxy-LTB4 and 3(S)-hydroxy-LTB4, also significantly reduced LTB4 production to levels as low as 10 ± 6% and 10 ± 7% of control levels, respectively, when present exogenously at 10 nM. Exogenous 5-hydroxy-6,8,11,14-eicosatetraenoic acid at concentrations as high as 10 nM produced no significant reduction in LTB4biosynthesis during zymosan-stimulated human neutrophil production of LTB4. The inhibitory effect of LTB4 could be partially reversed by the LTB4 receptor antagonist U 75302. Furthermore, an alternative stimulus, N-formyl-methionyl-leucyl-phenylalanine (100 nM), did not inhibit the production of LTB4 in opsonized zymosan-stimulated human neutrophils. These results suggest that activation of the LTB4 receptor on the human neutrophil during phagocytosis limits the ultimate biosynthesis of LTB4. This autocrine effect is opposite to that observed when neutrophils have much of the signal transduction pathways bypassed when stimulated with calcium ionophore A23187 or treated with exogenous free arachidonic acid.
Footnotes
-
Send reprint requests to: Dr. Robert C. Murphy, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, CO 80206.
-
↵1 This work was supported by a grant from the National Institutes of Health (HL25785) and a predoctoral training grant (GM07635).
-
↵2 Present address: Glaxo/Wellcome, 5 Moore Drive, Research Triangle Park, NC 27709.
- Abbreviations:
- LTB4
- leukotriene B4
- LC/MS/MS
- reverse-phase HPLC tandem mass spectrometry
- 5-HETE
- 5-hydroxy-6,8,11,14-eicosatetraenoic acid
- 20-OH-LTB4
- 20-hydroxy-LTB4
- fMLP
- N-formyl-methionyl-leucyl-phenylalanine
- LTA4
- leukotriene A4
- 5-HpETE
- 5-hydroperoxy-6,8,11,14-eicosatetraenoic acid
- cPLA2
- cytosolic phospholipase A2
- BSA
- bovine serum albumin
- HBSS
- Hank’s buffered saline solution
- PMN
- polymorphonuclear leukocyte
- PFB
- pentafluorobenzyl ester
- MRM
- multiple reaction monitoring
- Received March 5, 1998.
- Accepted May 26, 1998.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|